NCT06193304View on ClinicalTrials.gov

A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

August 25, 2014

Primary Completion Date

September 21, 2014

Study Completion Date

September 21, 2014

Conditions

Gaucher's Disease

Interventions

DRUG

Eliglustat

Pharmaceutical form:solution -Route of administration: Oral wihtout ingestion

Trial Locations (1)

47710

Covance Clinical Researsh Unit, Evansville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY